100000 - Document - Document and Entity Information
link:presentationLink
link:calculationLink
link:definitionLink
100010 - Statement - Condensed Consolidated Balance Sheets
link:presentationLink
link:calculationLink
link:definitionLink
100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
100030 - Statement - Condensed Consolidated Statements of Operations 2
link:presentationLink
link:calculationLink
link:definitionLink
100040 - Statement - Condensed Consolidated Statements of Operations
link:presentationLink
link:calculationLink
link:definitionLink
100050 - Statement - Condensed Consolidated Statements Of Series A Redeemable Preferred Stock And Stockholders' Deficit
link:presentationLink
link:calculationLink
link:definitionLink
100060 - Statement - Condensed Consolidated Statement of Cash Flows
link:presentationLink
link:calculationLink
link:definitionLink
995455 - Disclosure - Nature of Business
link:presentationLink
link:calculationLink
link:definitionLink
995465 - Disclosure - Summary of Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995475 - Disclosure - Fair Value Measurements
link:presentationLink
link:calculationLink
link:definitionLink
995485 - Disclosure - Restricted Cash
link:presentationLink
link:calculationLink
link:definitionLink
995495 - Disclosure - Supplemental Balance Sheet Information
link:presentationLink
link:calculationLink
link:definitionLink
995505 - Disclosure - Notes Payable
link:presentationLink
link:calculationLink
link:definitionLink
995515 - Disclosure - Preferred Stock
link:presentationLink
link:calculationLink
link:definitionLink
995525 - Disclosure - Warrants
link:presentationLink
link:calculationLink
link:definitionLink
995535 - Disclosure - Stockholders' Deficit
link:presentationLink
link:calculationLink
link:definitionLink
995545 - Disclosure - Stock-Based Compensation
link:presentationLink
link:calculationLink
link:definitionLink
995555 - Disclosure - Net Loss Per Share
link:presentationLink
link:calculationLink
link:definitionLink
995565 - Disclosure - US Government Contract
link:presentationLink
link:calculationLink
link:definitionLink
995575 - Disclosure - Leases
link:presentationLink
link:calculationLink
link:definitionLink
995585 - Disclosure - Commitments and Contingencies
link:presentationLink
link:calculationLink
link:definitionLink
995595 - Disclosure - Subsequent Events
link:presentationLink
link:calculationLink
link:definitionLink
995605 - Disclosure - Summary of Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995615 - Disclosure - Summary of Significant Accounting Policies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995625 - Disclosure - Fair Value Measurements (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995635 - Disclosure - Supplemental Balance Sheet Information (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995645 - Disclosure - Notes Payable (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995655 - Disclosure - Stock-Based Compensation (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995665 - Disclosure - Net Loss Per Share (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995675 - Disclosure - Nature of Business - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995685 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995695 - Disclosure - Summary of Significant Accounting Policies - Schedule of Customers Represent Greater Than 10% Of Revenue (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995705 - Disclosure - Summary of Significant Accounting Policies - Schedule of Customers Represent Greater Than 10% Of Accounts Receivable (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995715 - Disclosure - Summary of Significant Accounting Policies - Disaggregation of Total Revenue by Major Resource (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995725 - Disclosure - Summary of Significant Accounting Policies - Additional Information 1 (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995735 - Disclosure - Fair Value Measurements - Schedule of Financial Assets and Liabilities at Fair value on a Recurring Basis (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995745 - Disclosure - Fair Value Measurements - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995755 - Disclosure - Fair Value Measurements - Schedule of Estimated Fair Value of the Warrant Liability (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995765 - Disclosure - Fair Value Measurements - Schedule of Roll-forward of Fair Value of Common Stock Warrants (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995775 - Disclosure - Fair Value Measurements - Summary of Contingent Interest Payments (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995785 - Disclosure - Fair Value Measurements - Summary of Contingent Interest Payments (Parenthetical) (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995795 - Disclosure - Fair Value Measurements - Roll-Forward of Fair Value of Derivative Liability related to Term Loan with Related Party (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995805 - Disclosure - Restricted Cash - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995815 - Disclosure - Supplemental Balance Sheet Information - Schedule of Inventory (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995825 - Disclosure - Supplemental Balance Sheet Information - Schedule of Property and Equipment (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995835 - Disclosure - Supplemental Balance Sheet Information - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995845 - Disclosure - Supplemental Balance Sheet Information - Components of Accrued Expenses (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995855 - Disclosure - Notes Payable - Term Loan Agreement - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995865 - Disclosure - Notes Payable - Schedule of Debt (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995875 - Disclosure - Preferred Stock - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995885 - Disclosure - Warrants - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995895 - Disclosure - Stockholders' Deficit - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995905 - Disclosure - Stock-Based Compensation - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995915 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995925 - Disclosure - Stock-Based Compensation - Schedule of Estimated Assumptions Used to Calculate Weighted-Average Grant Date Fair Value of Options Granted (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995935 - Disclosure - Stock-Based Compensation - Schedule of Wainwright Contingent Warrant Activity (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995945 - Disclosure - Stock-Based Compensation - Schedule of Nonvested Restricted Stock Units Activity (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995955 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense for Stock Options Granted that was Recorded in the Company's Results of Operations (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995965 - Disclosure - Net Loss Per Share - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995975 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995985 - Disclosure - US Government Contract - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995995 - Disclosure - Leases - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996005 - Disclosure - Commitments and Contingencies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996015 - Disclosure - Subsequent Events - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
Pre-funded warrants.
Pre-funded Warrants [Member]
Pre-funded Warrants [Member]
Pre-Funded Warrants [Member]
Other, net [Member]
Other Nonoperating Income (Expense) [Member]
Statement [Line Items]
Statement [Line Items]
Notes Payable, Current
Notes Payable, Current, Total
Notes payable to related party
Customer D.
Customer D [Member]
Customer D [Member]
Liabilities, Fair Value Disclosure [Abstract]
Liabilities:
Debt Instrument [Axis]
Debt Instrument
Increase (Decrease) in Accounts Receivable
Accounts receivable
Plan Name [Domain]
Plan Name
Incentive from Lessor
Space build-out costs paid
Customer A.
Customer A [Member]
Customer A [Member]
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation
Surrender of shares due to tax withholding
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
Schedule of Wainwright Contingent Warrant Activity
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Summary of contingent interest payments.
Summary Of Contingent Interest Payments Table [Text Block]
Summary of Contingent Interest Payments
Revenue, Remaining Performance Obligation, Amount
Transaction price that is allocated to unsatisfied or partially satisfied performance obligations, that has not yet been recognized as revenue
Office Equipment [Member]
Office and Computer Equipment [Member]
Fair Value, Recurring and Nonrecurring [Table]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Costs and Expenses [Abstract]
Costs and expenses:
November 30, 2023 [Member]
November Thirty Two Thousand Twenty Three [Member]
November thirty two thousand twenty three.
Revenues [Abstract]
Revenue:
Cash paid for interest to related party
Interest Paid, Excluding Capitalized Interest, Operating Activities
Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount
Unrecognized compensation cost related to unvested stock options
Number of Operating Segments
Number of operating segments
Number of common shares issued upon conversion of convertible preferred stock
Number of Common Shares Issued Upon Conversion of Convertible Preferred Stock
Number of common shares issued upon conversion of convertible preferred stock.
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Weighted-Average Exercise Price Per Share, Exercisable
Stockholders' Equity, Reverse Stock Split
Reverse stock split description
Proceeds from issuance of common stock, gross.
Proceeds From Issuance Of Common Stock Gross
Aggregate gross sales amount of common stock
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV
Temporary Equity, Shares Issued
Series A redeemable convertible preferred stock, shares issued
Temporary equity, shares issued
Fair Value, Inputs, Level 2 [Member]
Level 2 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation
Office space, laboratory space, and equipment.
Office Space Laboratory Space And Equipment [Member]
Office Space, Laboratory Space, and Equipment [Member]
Fair Value Measurement [Domain]
Fair Value Measurement
Number of contract payment term
Number Of Contract Payment Term
Number of contract payment term.
Revenue, Remaining Performance Obligation, Percentage
Percentage of revenue recognition
Restricted Assets Disclosure [Text Block]
Restricted Cash
Pre-funded warrant and common stock warrant.
Pre-funded Warrant and Common Stock Warrant [Member]
Preferred Stock [Text Block]
Preferred Stock
Lessee, Operating Leases [Text Block]
Leases
Commitments and Contingencies Disclosure [Text Block]
Commitments and Contingencies
Stock, Class of Stock [Table]
Schedule Of Stock By Class [Table]
The term following the installation of the purchased product for maintenance services which include warranty, maintenance, and technical support services, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Maintenance Service Period
Maintenance Services period (in years)
AUSTRIA
Austria [Member]
Product and Service [Axis]
Product and Service
Derivatives, Policy [Policy Text Block]
Derivative Instruments
Depreciation, Depletion and Amortization
Depreciation and amortization
Depreciation, Depletion and Amortization, Total
Stock issued during period values issuance of common stock pre-funded warrants and series a and series b common stock warrants from private placement, net
Stock Issued During Period Values Issuance Of Common Stock Pre-funded Warrants And Series A And Series B Common Stock Warrants From Private Placement, Net
Issuance of common stock, Pre-Funded Warrants, and Series A and Series B Common Stock Warrants from private placement, net
Inventory, Work in Process and Raw Materials
Raw materials and work-in-process inventory
Inventory, Work in Process and Raw Materials, Total
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Collaborative Arrangement and Arrangement Other than Collaborative
Noncash Investing and Financing Items [Abstract]
Supplemental disclosures of noncash activities
Employee Stock [Member]
Employee Stock Purchase Plan [Member]
Concentration Risk Benchmark [Axis]
Concentration Risk Benchmark
Equity [Text Block]
Stockholders' Deficit
4% contingent interest beginning in Q4 2024, probability
Fair value derivative liability discount rate.
Fair Value Derivative Liability Discount Rate
Title and Position [Axis]
Tools, Dies and Molds [Member]
Manufacturing Tooling and Molds [Member]
Class of Warrant or Right [Axis]
Operating Lease Termination [Member]
Operating Lease Termination [Member]
Operating Lease Termination [Member]
Sale of Stock [Domain]
Sale of Stock
Cash and Cash Equivalents [Domain]
Cash and Cash Equivalents
Cancellation of Term Loan in exchange for common stock and Convertible Preferred Stock to related party
Cancellation of Term Loan in Exchange for Common Stock and Convertible Preferred Stock To Related Party
Cancellation of Term Loan in exchange for common stock and Convertible Preferred Stock to related party
Inventory, Work in Process, Net of Reserves
Work-in-process
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Entity Central Index Key
Entity Central Index Key
Percentage Of Common Stock Outstanding
Percentage Of Common Stock Outstanding
Percentage of common stock outstanding
Stock option plans two thousand and six and two thousand and fourteen.
Stock Option Plans Two Thousand And Six And Two Thousand And Fourteen [Member]
2006 and 2014 Stock Option Plans [Member]
Series A redeemable convertible preferred stock.
Series A Redeemable Convertible Preferred Stock [Member]
Series A Redeemable Convertible Preferred Stock [Member]
Warrant [Member]
Warrants to Purchase Common Stock [Member]
Common Stock Warrants [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Number of Shares, Forfeited
Debt Instrument, Maturity Date Range, End
Debt instrument, maturity date end
Accrued clinical trial and development expenses
Accrued Clinical Trial and Development Expenses
Accrued clinical trial and development expenses.
Increase (Decrease) in Operating Capital [Abstract]
Changes in operating assets and liabilities:
Aggregate number of common stock issued
Common Stock, Shares, Issued
Balance (in shares)
Balance (in shares)
Common stock, shares issued
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Stock Option Plan 2014 [Member]
Stock Option Plan2014 [Member]
2014 Stock Option Plan [Member]
Fair Value Measurement Inputs and Valuation Techniques [Table]
Measurement Input, Expected Dividend Rate [Member]
Expected Dividend Yield [Member]
Other Noncurrent Assets [Member]
Other Non-Current Assets [Member]
Increase (Decrease) in Prepaid Expense and Other Assets
Prepaid expenses and other assets
Share based compensation arrangement by share based payment award other than options grants in period gross value grant date fair value.
Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Grants In Period Gross Value Grant Date Fair Value
Aggregate fair value of restricted stock units granted
Probability-Weighted Discounted Cash Flow Model [Member]
Probability-weighted discounted cash flow model.
Probability Weighted Discounted Cash Flow Model [Member]
Operating Leases Entered Into September2021.
Operating Leases Entered Into September2021 [Member]
Operating Leases Entered Into September 2021 [Member]
Income Statement [Abstract]
Entity Address, State or Province
Entity Address, State or Province
Stock issued during period shares issuance of common stock pre-funded warrants and series a and series b common stock warrants from private placement, net
Stock Issued During Period Shares Issuance Of Common Stock Pre-funded Warrants And Series A And Series B Common Stock Warrants From Private Placement, Net
Issuance of common stock, Pre-Funded Warrants, and Series A and Series B Common Stock Warrants from private placement, net (in shares)
Class of Warrant or Right [Table]
Class Of Warrant Or Right [Table]
Stock issued during period, value, issuance of common stock warrant upon cashless exercises.
Stock Issued During Period, Value, Issuance Of Common Stock Warrant Upon Cashless Exercises
Issuance of common stock upon Common Stock Warrant cashless exercises
Collaborative arrangement initial value of consideration.
Collaborative Arrangement Initial Value Of Consideration
Initial value of consideration receivable
Redeemable Noncontrolling Interest [Line Items]
December 31, 2024 [Member]
December Thirty-One, Two Thousand Twenty Four [Member]
December Thirty-One, Two Thousand Twenty Four.
Concentration Risk Type [Domain]
Concentration Risk Type
Portion at Fair Value Measurement [Member]
Fair Value Disclosure Item Amounts [Default]
Portion at Fair Value Measurement [Member] [Default]
Contract with Customer, Liability, Revenue Recognized
Revenue recognized relating to contract liabilities
Customer [Axis]
Customer
Customer Concentration Risk [Member]
Customer Concentration Risk [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Aggregate Intrinsic Value, Exercisable
Number of voting rights per share of common stock
Common Stock Number Of Votes Per Share
Represents the number of votes per share of common stock, which the holders of outstanding shares entitled to receive.
Payment of debt issuance costs
Payments of Debt Issuance Costs
Conversion of preferred stock into common stock
Preferred Stock, Convertible Shares
Preferred Stock, Convertible, Shares Issuable
Cover [Abstract]
Subsequent Event [Line Items]
Earnings Per Share, Basic
Earnings Per Share, Basic, Total
Net loss per share - basic
Contract with Customer, Asset, after Allowance for Credit Loss
Contract assets
Contract with Customer, Asset, after Allowance for Credit Loss, Total
Cost of product revenue.
Cost Of Product Revenue Policy [Text Block]
Cost of Product Revenue
Customer E.
Customer E [Member]
Customer E [Member]
Operating Lease Entered into August 2010 [Member]
Operating Leases Entered Into August2010 [Member]
Represents information pertaining to operating leases entered into August 2010.
Non-cash interest expense to related party
Paid in Kind Interest Expense to Related Party
Paid in kind interest expense to related party.
Contingent payment of interest, percentage.
Contingent Payment Of Interest Percentage
Contingent payment of interest rate
Contract with Customer, Liability, Current
Deferred revenue
Wainwright [Member]
H.C. Wainwright & Co., LLC.
H.C. Wainwright & Co., L L C [Member]
Non refundable fee
Payment For Legal Hearing Fee
Payment for legal hearing fee.
Series A and Series B Common Stock Warrants
Series A and Series B Common Stock Warrants [Member]
Series A and Series B Common Stock Warrants [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Explanation
Remaining performance obligation, expected timing of satisfaction
Share-Based Payment Arrangement, Expense
Stock-based compensation expense
Preferred stock convertible shares outstanding.
Preferred Stock Convertible Shares Outstanding
Preferred Stock, Convertible Shares Outstanding
Mexico [Member]
MEXICO
Retained Earnings (Accumulated Deficit)
Accumulated deficit
Accumulated deficit
Retained Earnings (Accumulated Deficit), Total
Space build-out costs.
Space Build Out Costs
Space build-out costs
Plan Name [Axis]
Plan Name
Placement Agent Derivatives.
Placement Agent Derivatives [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Number of Shares Outstanding, end of the period
Number of Shares Outstanding, beginning of the period
Represents the information pertaining to office, laboratory and manufacturing space.
Office Laboratory And Manufacturing Space [Member]
Office Laboratory And Manufacturing Space
Assets, Current [Abstract]
Current assets:
Common stock reserved for issuance
Common Stock, Capital Shares Reserved for Future Issuance
US [Member]
UNITED STATES
Cashless exercise of common stock warrants.
Cashless Exercise Of Common Stock Warrants
Cashless exercise of Common Stock Warrants
Net Cash Provided by (Used in) Operating Activities
Net cash used in operating activities
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Forfeited
Product and Service [Domain]
Product and Service
Lessee, Operating Lease, Term of Contract
Term of lease
Weighted-Average Remaining Contractual Term (In years), Outstanding on September 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms
Debt Instrument [Line Items]
Debt Instrument [Line Items]
Debt Instrument, Term
Debt term (in years)
Property, Plant and Equipment, Net
Property and equipment, net
Property and equipment, net
November 15, 2024
November Fifteen Two Thousand Twenty Four [Member]
November Fifteen Two Thousand Twenty Four [Member]
Contract with Customer, Liability, Noncurrent
Deferred revenue, net of current portion
Net Cash Provided by (Used in) Operating Activities [Abstract]
Cash flows from operating activities
Placement Agent Warrant.
Placement Agent Warrant [Member]
Fair Value, Recurring [Member]
Recurring [Member]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Schedule of Financial Assets and Liabilities at Fair value on a Recurring Basis
Common Stock, Par or Stated Value Per Share
Common stock, par value
Common stock, par value (in dollars per share)
Options to Purchase Common Shares [Member]
Measurement Input Type [Domain]
Measurement Input Type
Contract with Customer, Liability
Contract liabilities
Contract with Customer, Liability, Total
Statement of Cash Flows [Abstract]
Counterparty Name [Axis]
Counterparty Name
Antidilutive Securities, Name [Domain]
Antidilutive Securities, Name
Collaborative Arrangement Additional Funding Amount Received.
Collaborative Arrangement Additional Funding Amount Received
Collaborative arrangement additional funding amount received
Number of shares issuable for warrants outstanding (in shares)
Number of shares issuable for warrants outstanding
Aggregate gross sales amount of common stock
Selling, General and Administrative Expenses [Member]
Selling, General and Administrative [Member]
Maximum bidding price stock for last thirty consecutive business days
Maximum Bidding Price Stock for Last Thirty Consecutive Business Days
Maximum bidding price stock for last thirty consecutive business days.
Equity Components [Axis]
Equity Components
Entity Address, Address Line One
Entity Address, Address Line One
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Schedule of Net Loss Per Share Presented in Consolidated Statements of Operations and Comprehensive Loss
Employee-related Liabilities, Current
Accrued payroll and compensation
Employee-related Liabilities, Current, Total
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Number of Shares, Granted
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]
Schedule of Customers Represent Greater Than 10% Of Accounts Receivable
Valuation Approach and Technique [Axis]
Valuation Approach and Technique
Series A Redeemable Convertible Preferred Stock [Member]
Series A Convertible Preferred Stock [Member]
Series a convertible preferred stock.
Series A Convertible Preferred Stock [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment [Line Items]
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted Cash And Cash Equivalents Items [Line Items]
Subsequent Event Type [Axis]
Total other income (expense)
Nonoperating Income (Expense)
June 30, 2024 [Member]
June Thirty Two Thousand Twenty Four [Member]
June Thirty Two Thousand Twenty Four [Member]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
Canaccord Genuity LLC.
Canaccord Genuity L L C [Member]
Canaccord [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Weighted-average risk-free interest rate
Risk-free interest rate
Non-US [Member]
Non-US [Member]
Class of warrant or right exercised, number.
Class of Warrant or Right Exercised, Number
Number of warrants exercised
Customer B.
Customer B [Member]
Customer B [Member]
Legal Entity of Counterparty, Type [Axis]
Number of Shares Outstanding, Nonvested on September 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Number of Shares Outstanding, Nonvested on December 31, 2023
Common stock warrants.
Common Stock Warrants [Member]
Common Stock Warrants [Member]
Amendment Flag
Amendment Flag
Federal deposit insurance corporation.
Federal Deposit Insurance Corporation [Member]
FDIC [Member]
Operating Lease, Liability, Noncurrent
Operating lease liabilities, net of current portion
Interest expense to related party
Interest Expense to Related Party
Interest expense to related party.
Conversion of loan to common and preferred stock
Debt surrendered for cancellation in exchange for convertible preferred stock issued
Conversion of debt to equity
Total notes payable to related party
Notes Payable
Geographic Concentration Risk [Member]
Geographic Concentration Risk [Member]
Inventory, Finished Goods, Net of Reserves
Finished goods
Debt Instrument, Name [Domain]
Debt Instrument, Name
Additional Paid in Capital, Common Stock
Additional paid-in capital
Waiver and consent to term loan agreement.
Waiver and Consent to Term Loan Agreement [Member]
Mr. Sprague, Mr. Giffin, and Mr. Gibbs.
Mr. Sprague, Mr. Giffin, and Mr. Gibbs [Member]
Mr. Sprague, Mr. Giffin, and Mr. Gibbs [Member]
Preferred stock voting rights per share
Preferred Stock, Voting Rights
Preferred stock, voting rights
Net loss
Net loss
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Issuance of common stock from exercise of stock options (in shares)
Number of Shares, Exercised
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Number of Shares, Exercisable
Research and Development Expense [Member]
Research and Development [Member]
Customer [Domain]
Customer
Schedule of Debt [Table Text Block]
Schedule of Debt
Contractual deferred interest rate during interest only payments for funds borrowed, under the debt agreement.
Debt Instrument Deferred Interest Rate Interest Only Payment
Deferred interest rate (as a percent)
Manufacturing Facility [Member]
Manufacturing Equipment [Member]
Debt Instrument, Maturity Date Range, Start
Debt instrument, maturity date start
Debt instrument payable in cash quarterly percentage.
Debt Instrument Payable in Cash Quarterly Percentage
Payable in cash quarterly (as a percent)
Equity Component [Domain]
Equity Component
Statistical Measurement [Domain]
Statistical Measurement
Supplemental Balance Sheet Disclosures [Text Block]
Supplemental Balance Sheet Information
Disclosure of accounting policy for reporting unaudited interim financial information for the stated accounting period.
Unaudited Interim Financial Information Policy [Text Block]
Unaudited Interim Financial Information
Other, net
Other Nonoperating Income (Expense)
Other Nonoperating Income (Expense), Total
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period
Expiration period
Additional interest rate on all outstanding obligations during the occurrence and continuance of an event of default.
Debt Instrument Event Of Default Additional Interest Rate
Additional interest rate, event of default (as a percent)
Furniture and Fixtures [Member]
Furniture [Member]
Disaggregation of Revenue [Table]
Disaggregation Of Revenue [Table]
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]
Reconciliation of cash, cash equivalents and restricted cash at end of period
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Net loss
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total
Preferred stock, shares issued to related party
Number of preferred stock sold
Exchange of preferred stock
Instrument rentals.
Instrument Rentals [Member]
Instrument Rentals [Member]
Schedule of Derivative Liabilities at Fair Value [Table Text Block]
Roll-Forward of Fair Value of Derivative Liability related to Term Loan with Related Party
Inventory, Net [Abstract]
Change in fair value of derivative related to Term Loan with related party
Change in fair value of derivative related to Term Loan with related party
Change in Fair Value of Derivative Related to Term Loan with Related Party
Change in fair value of derivative related to Term Loan with related party.
Accrued Royalties
Royalties accrued
Prepaid Expense and Other Assets, Current
Prepaid expenses and other current assets
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Weighted-Average Exercise Price Per Share, Forfeited
Preferred Stock, Liquidation Preference, Value
Preferred Stock Liquidation Preference Value
Percentage of additional warrants
Percentage of Additional Warrants
Percentage of additional warrants
Unbilled accounts receivable.
Unbilled Accounts Receivable
Unbilled accounts receivable
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative
Class of Stock [Domain]
Class of Stock
Measurement Input, Share Price [Member]
Share Price [Member]
Issuance of Series A and Series B Convertible Preferred Stock to related party
Temporary equity stock issued during period shares value new issues
Temporary Equity Stock Issued During Period Shares Value New Issues
Collaborative Arrangement Disclosure [Text Block]
US Government Contract
New Sales Agreement [Member]
New sales agreement.
New Sales Agreement [Member]
New Sales Agreement
Common Stock, Shares, Outstanding
Common stock, shares outstanding
Common Stock, Shares, Outstanding, Beginning Balance
Common Stock, Shares, Outstanding, Ending Balance
Contingent Consideration by Type [Axis]
Contingent Consideration by Type
Collaborative arrangement first contract option value exercised.
Collaborative Arrangement First Contract Option Value Exercised
First contract option value exercised
Preferred stock, par value
Preferred Stock, Par or Stated Value Per Share
Preferred stock, par value (in dollars per share)
Revenue Benchmark [Member]
Revenue [Member]
Common Stock, Share Subscribed but Unissued, Subscriptions Receivable
Aggregate subscription amount
Antidilutive Securities [Axis]
Antidilutive Securities
Proceeds from sale of equity
Proceeds from Issuance or Sale of Equity
Proceeds from Issuance or Sale of Equity, Total
Product, consumables.
Product Consumables [Member]
Product Consumables [Member]
Cash
Cash
February two thousand and twenty three pre-funded warrants.
February Two Thousand and Twenty Three Pre-Funded Warrants [Member]
February 2023 Pre-Funded Warrants [Member]
Entity Interactive Data Current
Entity Interactive Data Current
Product [Member]
Product [Member]
Total Product Revenue [Member]
Lease Expiration Date
Lease expiration date
Cost of Sales [Member]
Cost of Product Revenue [Member]
Legal Entity Type of Counterparty [Domain]
Document Quarterly Report
Document Quarterly Report
Proceeds from at the market facility
Proceeds from At the Market Facility
Proceeds from at the market facility.
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Vested
Cash, cash equivalents and restricted cash
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Ending Balance
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Beginning Balance
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Total
Statement of Financial Position Location, Balance [Axis]
Balance Sheet Location
Statistical Measurement [Axis]
Statistical Measurement
Contribution.
Contribution [Member]
Contribution [Member]
Cost of Goods and Services Sold
Cost of product revenue
Cost of Goods and Services Sold, Total
Total assets
Assets, Fair Value Disclosure
Related and Nonrelated Parties [Domain]
Related Party
Restricted Cash and Cash Equivalents [Axis]
Restricted Cash and Cash Equivalents
Represents the T2Dx Instruments and components of instruments.
T2 Dx Instruments And Components [Member]
T2-Owned Instruments and Components [Member]
Disaggregation of Revenue [Table Text Block]
Disaggregation of Revenue by Major Source
May 2024 pre-funded warrants.
May 2024 Pre-Funded Warrants [Member]
Proceeds from secondary offering, net of issuance costs.
Proceeds from Secondary Offering, Net of Issuance Costs
Proceeds from secondary offering, net of issuance costs
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Shares available for grant
Basis of Presentation and Significant Accounting Policies [Text Block]
Summary of Significant Accounting Policies
Secondary Public Offering.
Secondary Public Offering [Member]
Secondary Offering [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Granted
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Weighted-average period
Wainwright warrant issued in connection with offering costs of may two thousand twenty four private offering.
Wainwright Warrant Issued In Connection With Offering Costs Of May Two thousand Twenty Four Private Offering
Wainwright Warrant issued in connection with offering costs of May 2024 private offering
Stock issued during period shares issuance of common stock to related party
Stock Issued During Period Shares Issuance Of Common Stock To Related Party
Issuance of common stock to related party (in shares)
Research and Development Expense, Policy [Policy Text Block]
Research and Development Costs
Measurement Basis [Axis]
Measurement Basis
Statement of Income Location, Balance [Axis]
Income Statement Location
Assets
Total assets
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term
Expected terms
Expected term
Schedule of Long-Term Debt Instruments [Table]
Debt Instrument [Table]
Percentage of agent service fee.
Percentage Of Agent Service Fee
Percentage of agent service fee
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Number of Shares, Vested
Restricted Cash and Cash Equivalents, Noncurrent
Restricted cash
Restricted Cash and Cash Equivalents, Noncurrent, Total
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Standards
Entity Address, City or Town
Entity Address, City or Town
AOCI Attributable to Parent [Member]
Accumulated Other Comprehensive Loss [Member]
Equity [Abstract]
Assets:
Assets, Fair Value Disclosure [Abstract]
Payments of Stock Issuance Costs
Issuance costs related to offering
Debt instrument unaccrued paid in kind interest.
Debt Instrument Unaccrued Paid In Kind Interest
Less: unaccrued paid-in-kind interest
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Number of Shares, Forfeited
Stock issued during period, value, issuance of common stock upon pre funded warrant exercises.
Stock Issued During Period, Value, Issuance Of Common Stock Upon Pre Funded Warrant Exercises
Issuance of common stock upon Pre-Funded Warrant exercises
Leases.
Leases [Line Items]
Leases [Line Items]
Customer F [Member]
Customer F [Member]
Customer F.
Balance at end
Derivative liability related to Term Loan
Derivative liability related to Term Loan, net of current portion
Derivative liability, noncurrent
Balance at beginning
Share Price
Share price
Stock price
The cash inflow (outflow) associated with the amount received from entity's first offering of stock to the public, net of issuance costs.
Proceeds From Issuance Initial Public Offering Net Of Issuance Costs
Proceeds from public offering, net of issuance costs
Private Placement Offering [Member]
Private Placement [Member]
Represents information pertaining to a Co-Development Partnership Agreement with a third party to develop certain products.
Co Development Partnership Agreement [Member]
Co Development Partnership Agreement [Member]
Share-Based Payment Arrangement [Text Block]
Stock-Based Compensation
Construction in Progress [Member]
Construction in Progress [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized
Shares available for authorization
Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan (in shares)
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture, Total
Sales agreement.
Sales Agreement [Member]
Sales Agreement [Member]
Mr. Sprague and Mr. Gibbs [Member]
Mr Sprague And Mr Gibbs [Member]
Mr Sprague And Mr Gibbs [Member]
Share based compensation arrangement by share based payment award options grants in period gross value grant date fair value.
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Value Grant Date Fair Value
Aggregate fair value of options granted
Fair Value Disclosures [Abstract]
Number of installments to pay retention bonus
Number of Installments to Pay Retention Bonus
Number of installments to pay retention bonus.
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
Weighted-Average Exercise Price Per Share, Cancelled
Amount of aggregate consideration receivable under collaborative arrangement.
Collaborative Arrangement Aggregate Consideration
Aggregate consideration receivable
Preferred Stock, Redemption Price Per Share
Preferred stock, redemption price
Issuance of common stock from secondary offering, net
Stock Issued During Period, Value, New Issues
Equity stock issued during period shares new issues
Equity Stock Issued During Period Shares New Issues
Conversion of Series A and Series B Convertible Preferred Stock into common stock by related party (in shares)
Liabilities, Current [Abstract]
Current liabilities:
Lessor and lessee, leases.
Lessor And Lessee, Leases [Policy Text Block]
Leases
Lease Contractual Term [Axis]
Lease Contractual Term
Redemption of Series A Redeemable Preferred Stock issued to related party, (in Shares)
Stock Redeemed or Called During Period, Shares
Accounts Receivable [Member]
Document Type
Document Type
Title of 12(b) Security
Title of 12(b) Security
Cash and Cash Equivalents, at Carrying Value
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value, Total
Statement of Financial Position Location, Balance [Domain]
Balance Sheet Location
Stock option plan 2014 and inducement plan.
Stock Option Plan 2014 And Inducement Plan [Member]
2014 Stock Option Plan and Inducement Plan [Member]
Statement of Stockholders' Equity [Abstract]
Document Fiscal Period Focus
Document Fiscal Period Focus
Commitments and contingencies.
Commitments And Contingencies [Table]
Commitments And Contingencies [Table]
Research and Development Expense
Research and development
Research and Development Expense, Total
Payment, Tax Withholding, Share-Based Payment Arrangement
Payment of employee restricted stock tax withholdings
Number of stock options granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Number of Shares, Granted
Asset Class [Domain]
Property, Plant and Equipment, Gross
Property and equipment, gross
Property, Plant and Equipment, Gross, Total
Property, Plant and Equipment, Gross, Beginning Balance
Property, Plant and Equipment, Gross, Ending Balance
Restrictions on Cash and Cash Equivalents [Table]
Schedule Of Restricted Cash And Cash Equivalents [Table]
Product Information [Line Items]
Product Information [Line Items]
Conversion price per share.
Conversion Price per Share
Conversion price per share
Subsequent Event Type [Domain]
Measurement Input, Expected Term [Member]
Expected Term [Member]
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Schedule of Estimated Assumptions Used to Calculate Weighted-Average Grant Date Fair Value of Options Granted
Estimate of Fair Value Measurement [Member]
Estimate of Fair Value Measurement [Member]
Represents the information pertaining to laboratory space.
Laboratory Space [Member]
Laboratory Space [Member]
Accrued final payment fee on term loan current.
Accrued Final Payment Fee On Term Loan Current
Accrued final payment fee on Term Loan with related party
Represents the amount of annual licensing fees agreed to be paid by the company.
License Fees Payable
Annual license fee payable
Nature of business line items.
Nature Of Business [Line Items]
Nature Of Business [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights
Exercise price of warrants
Financial Instruments [Domain]
Financial Instruments
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period
Class of Warrant or Right [Line Items]
Class of Warrant or Right [Line Items]
Sale of Stock [Axis]
Sale of Stock
Net Cash Provided by (Used in) Investing Activities [Abstract]
Cash flows from investing activities
Term Loan Agreement due 2025 including PIK interest,before unamortized discount and issuance costs
Debt instrument carrying amount including paid in kind interest before unamortized discount and issuance costs.
Debt Instrument Carrying Amount Including Paid In Kind Interest Before Unamortized Discount And Issuance Costs
Total including PIK interest, before unamortized discount and issuance costs
Class of Warrant or Right, Date from which Warrants or Rights Exercisable
Warrants exercisable date
Cost, Depreciation
Depreciation expense recorded from instuments
Co Development Partnership Agreement Option Three [Member]
Co Development Partnership Agreement Option Three [Member]
Co Development Partnership Agreement Option Three [Member]
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
Schedule of Nonvested Restricted Stock Units Activity
Revenue from Contract with Customer, Excluding Assessed Tax, Total
Revenue from Contract with Customer, Excluding Assessed Tax
Total revenue
Revenue
Redemption of Series A Redeemable Preferred Stock issued to related party (in Shares)
Temporary Equity Stock Issued During Period Redemption Shares
Temporary equity stock issued during period redemption shares.
Lease expiration month and year.
Lease Expiration Month And Year
Lease expiration month and year
Warrants and Rights Note Disclosure [Abstract]
Selling, General and Administrative Expense
Selling, general and administrative
Selling, General and Administrative Expense, Total
Series B Preferred Stock [Member]
Series B Preferred Stock [Member]
Customer C.
Customer C [Member]
Customer C [Member]
Credit Facility [Domain]
Credit Facility
Geographic information.
Geographic Information Policy [Text Block]
Geographic Information
Depreciation and amortization
Depreciation, Depletion and Amortization, Nonproduction
Depreciation, Depletion and Amortization, Nonproduction, Total
Employee and nonemployee stock options.
Employee And Nonemployee Stock Options [Member]
Stock Options [Member]
Other Accrued Liabilities, Current
Other accrued expenses
Increase (Decrease) in Accounts Payable
Accounts payable
Increase (Decrease) in Accounts Payable, Total
Liabilities and Equity [Abstract]
Liabilities and stockholders' deficit
Document Period End Date
Document Period End Date
Net Cash Provided by (Used in) Financing Activities
Net cash provided by financing activities
CRG and Affiliated Entities [Member]
CRG and Affiliated Entities [Member]
CRG and affiliated entities.
Represents information pertaining to an agreement with a third party for licensing.
License Agreement [Member]
License Agreement [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Anti-dilutive securities excluded from the computation of diluted net loss per share
Series B Redeemable Convertible Preferred Stock [Member]
Series b redeemable convertible preferred stock member.
Series B Redeemable Convertible Preferred Stock Member
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Stock-based compensation expense
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total
Debt Conversion, Converted Instrument, Amount
Aggregate purchase price
Sale of Stock, Consideration Received on Transaction
Total proceeds from offering
Landlord.
Landlord [Member]
Accrued Liabilities, Current
Accrued expenses and other current liabilities
Total accrued expenses and other current liabilities
Derivative Liability, Current
Warrant liabilities
Derivative liability related to Term Loan with related party
Royalty on net sales sublicensing gross revenue.
Royalty On Net Sales Sublicensing Gross Revenue
Royalty on net sales sublicensing gross revenue
Leases.
Leases [Table]
Leases [Table]
Trading Symbol
Trading Symbol
Equity, Attributable to Parent
Balance
Balance
Total stockholders’ deficit
Stockholders' deficit
Issuance of Series A and Series B Convertible Preferred Stock to related party (in shares)
Temporary Equity Stock Issued During Period Shares New Issues
Temporary equity stock issued during period shares new issues.
Long-Lived Tangible Asset [Axis]
Long-Lived Tangible Asset
Component of common stock capital shares reserved for future issuance.
Component Of Common Stock Capital Shares Reserved For Future Issuance
Shares available for future issuance under stock incentive plan
Class of Warrant or Right, Outstanding
Number of warrants outstanding
Represents the T2dx Instruments in service.
T2 Owned Instruments In Service [Member]
T2 Owned Instruments in Service [Member]
Restricted Stock Units (RSUs) [Member]
Restricted Stock Units [Member]
Number of shares sold
Sale of Stock, Number of Shares Issued in Transaction
Number of shares issued/sold
Property, Plant and Equipment [Table]
Schedule Of Property Plant And Equipment [Table]
Selling, General and Administrative Expenses, Policy [Policy Text Block]
Selling, General and Administrative Expenses
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Summary of Stock-Based Compensation Expense for Stock Options Granted that was Recorded in the Company's Results of Operations
Nature of Operations [Text Block]
Nature of Business
Accrued Liabilities [Member]
Accrued Liabilities [Member]
Measurement Input, Discount Rate [Member]
Measurement Input, Discount Rate [Member]
Security deposit
Restricted cash
Security deposit
Measurement Input Type [Axis]
Measurement Input Type
Geographical [Axis]
Geographical
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Unrecognized compensation cost related to non-vested stock options
Leases [Abstract]
Equipment [Member]
Laboratory Equipment [Member]
Equity Distribution Agreement [Member]
Equity Distribution Agreement [Member]
Equity distribution agreement.
Proceeds from Issuance of Long-Term Debt
Proceeds from issuance of long-term debt
Proceeds from Issuance of Long-Term Debt, Total
Concentration Risk, Percentage
Total revenue (as a percent)
Total accounts receivable (as a percent)
Conversion of Series B Convertible Preferred Stock into common stock by related party
Stock Issued During Period, Value, Conversion of Convertible Securities
Related Party [Member]
Related Party [Member]
Class of Stock [Line Items]
Class Of Stock [Line Items]
Measurement Input, Price Volatility [Member]
Expected Volatility [Member]
Gain (Loss) on Derivative Instruments, Net, Pretax, Total
Gain (Loss) on Derivative Instruments, Net, Pretax
Change in fair value of derivatives with placement agent
Entity A [Member]
Entity A [Member]
Entity A member.
Stock issued during period shares issuance of common stock and pre funded warrant upon public offering, net.
Stock Issued During Period Shares Issuance Of Common Stock And Pre Funded Warrant Upon Public Offering Net
Issuance of common stock and Pre-Funded Warrant from public offering, net (in shares)
Estimated liability pertaining to lease.
Estimated Liability Pertaining to Lease
Estimated liability pertaining to lease
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Expected dividend yield
Derivative liability related to Term Loan with related party
Derivative Liability Related to Term Loan with Related Party
Derivative liability related to Term Loan with related party.
Security Exchange Name
Security Exchange Name
Counterparty Name [Domain]
Counterparty Name
Measurement Input, Risk Free Interest Rate [Member]
Risk-free Interest Rate [Member]
Schedule of Customers Represent Greater Than 10% Of Revenue
Schedule of Entities and Customers Represent Greater Than 10% Of Revenue
Revenue from External Customers by Geographic Areas [Table Text Block]
Series A warrant.
Series A Warrant [Member]
Series A Warrants [Member]
Long-Lived Tangible Asset [Domain]
Long-Lived Tangible Asset
Class of Stock [Axis]
Class of Stock
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Less accumulated depreciation and amortization
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance
Contingent Interest Beginning in Q4 2024 [Member]
Scenario one.
Scenario One [Member]
Fair Value Disclosures [Text Block]
Fair Value Measurements
Software and Software Development Costs [Member]
Software [Member]
Amount of increase (decrease) in operating lease liabilities.
Increase Decrease In Operating Lease Liabilities
Operating lease liabilities
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Weighted average fair value of options granted
Original expected period of contracts for which value of unsatisfied performance obligations not to be disclosed.
Original Expected Period Of Contracts For Which Value Of Unsatisfied Performance Obligations Not To Be Disclosed
Original expected period of contracts for which value of unsatisfied performance obligations not to be disclosed
Shares converted
Conversion of Stock, Shares Converted
Subsequent Event [Member]
Subsequent Event [Member]
Maximum [Member]
Maximum [Member]
Liabilities and Equity
Total liabilities and stockholders' deficit
Operating Lease, Right-of-Use Asset
Operating lease right-of-use assets
Supplemental Cash Flow Information [Abstract]
Supplemental disclosures of cash flow information
Earnings Per Share, Diluted
Earnings Per Share, Diluted, Total
Net loss per share - diluted
Leasehold Improvements [Member]
Leasehold Improvements [Member]
Cash, cash equivalents, marketable securities and restricted cash
Cash, cash equivalents marketable securities and restricted cash.
Cash Cash Equivalents Marketable Securities And Restricted Cash
Cash, cash equivalents, marketable securities and restricted cash
Collaborative arrangement additional funding amount to be received.
Collaborative Arrangement Additional Funding Amount To Be Received
Collaborative arrangement additional funding amount to be received
Reverse stock split rounding adjustment (in shares)
Remaining shares issued
Stock issued during period, shares, stock splits
Leased T2-owned instruments.
Leased T2 Owned Instruments [Member]
Leased T2 Owned Instruments [Member]
Exercise of warrants.
Exercise Of Warrants [Member]
Exercise of Warrants [Member]
Liabilities
Total liabilities
Trading days
Trading Days
Trading days.
Accounts Receivable, after Allowance for Credit Loss, Total
Accounts Receivable, after Allowance for Credit Loss
Accounts receivable, net
Fair Value Hierarchy and NAV [Domain]
Fair Value Hierarchy and NAV
Nature of business table.
Nature Of Business [Table]
Nature Of Business [Table]
Assets, Current
Total current assets
Net cash used in investing activities
Net Cash Provided by (Used in) Investing Activities
Office Research Laboratory and Manufacturing Space.
Office Research Laboratory And Manufacturing Space [Member]
Office, Research, Laboratory and Manufacturing Space [Member]
Issuance of common stock from secondary offering, net (in shares)
Stock Issued During Period, Shares, New Issues
Number of shares issued/sold
Settlement of warrant due to cashless exercise.
Settlement Of Warrant Due To Cashless Exercise
Settlement due to cashless exercise
Product, instruments.
Product Instruments [Member]
Product Instruments [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period
Vesting period
Class of warrant or right maturity date.
Class Of Warrant Or Right Maturity Date
Warrants maturity term
Entity Filer Category
Entity Filer Category
Term loan agreement.
Term Loan Agreement [Member]
Term Loan Agreement [Member]
Property, Plant and Equipment [Abstract]
Restricted Cash [Abstract]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right
Number of securities called by each warrant
Stock issued during period, shares, issuance of common stock upon pre funded warrant exercises.
Stock Issued During Period, Shares, Issuance Of Common Stock Upon Pre Funded Warrant Exercises
Issuance of common stock upon Pre-Funded Warrant exercises (in shares)
Current Fiscal Year End Date
Current Fiscal Year End Date
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value
Fair value of vested stock options
Represents information pertaining to operating leases entered into May 2013.
Operating Leases Entered Into May2013 [Member]
Operating Leases Entered Into May 2013 [Member]
Issuance of warrants.
Issuance of Common Stock Warrant
Issuance of Placement Agent Warrant
Issuance of Placement Agent Derivatives
Supplemental balance sheet information.
Supplemental Balance Sheet Information [Line Items]
Supplemental Balance Sheet Information [Line Items]
Temporary Equity, Par or Stated Value Per Share
Series A redeemable convertible preferred stock, par value (in dollars per share)
Share-Based Payment Arrangement, Noncash Expense
Stock-based compensation expense
Share-Based Payment Arrangement, Noncash Expense, Total
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Aggregate Intrinsic Value, Outstanding
Related and Nonrelated Parties [Axis]
Related Party
Entity A [Member]
Biomedical Advanced Research and Development Authority.
Biomedical Advanced Research And Development Authority [Member]
Biomedical Advanced Research and Development Authority [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date
Entity Registrant Name
Entity Registrant Name
Series B Common Stock Warrant
Series B Common Stock Warrant [Member]
Stock issued during period values issuance of common stock to related party
Stock Issued During Period Values Issuance Of Common Stock To Related Party
Issuance of common stock to related party
Issuance costs related to common stock warrants.
Issuance Costs Related To Common Stock Warrants
Issuance costs related to Common Stock Warrants
2006 Plan [Member]
Amended and Restated 2006 Employee, Director and Consultant Stock Plan [Member]
Amended and Restated 2006 Employee, Director and Consultant Stock Plan.
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Wainwright warrant.
Wainwright Warrant [Member]
Wainwright Warrant [Member]
Earnings Per Share [Text Block]
Net Loss Per Share
Debt Instrument, Maturity Date
Debt maturity date
Entity Emerging Growth Company
Entity Emerging Growth Company
Money Market Funds [Member]
Money Market Accounts [Member]
Series B Convertible Preferred Stock [Member]
Series B Convertible Preferred Stock [Member]
Series B convertible preferred stock.
Series B Convertible Preferred Shares [Member]
Weighted Average Number of Shares Outstanding, Basic
Weighted Average Number of Shares Outstanding, Basic, Total
Weighted-average number of shares, basic
Weighted-average number of common shares used in computing net loss per share - basic
Security deposit received.
Security Deposit Received
Security deposit received from landlord
Warrants Not Settleable in Cash, Fair Value Disclosure
Fair value of warrant liability
Balance at Beginning
Balance at End
Represents information pertaining to operating leases entered into November 2014.
Operating Leases Entered Into November2014 [Member]
Operating Lease Entered into November 2014 [Member]
Common Stock, Shares Authorized
Common stock, shares authorized
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation
Surrender of shares due to tax withholding (in shares)
Interest Payable, Current
Accrued interest
Collaborative arrangement option contract value exercised.
Collaborative Arrangement Option Contract Value Exercised
Option contract value exercised
Proceeds from Issuance of Common Stock
Proceeds from issuance of common stock
Concentration Risk Type [Axis]
Concentration Risk Type
Fair Value, Inputs, Level 1 [Member]
Level 1 [Member]
Debt Disclosure [Abstract]
Final fee as a percentage of the amount of principal outstanding upon repayment.
Debt Instrument Final Payment Fee Percentage
Final fee as a percentage of the principal outstanding (as a percent)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Weighted-Average Exercise Price Per Share, Vested or expected to vest
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Weighted-Average Exercise Price Per Share, Granted
Financial Instrument [Axis]
Financial Instrument
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Weighted-Average Remaining Contractual Term, Outstanding
Earnings Per Share, Policy [Policy Text Block]
Net Loss Per Share
Percentage of cash fee against aggregate gross excercise price.
Percentage of Cash Fee against Aggregate Gross Excercise Price
Percentage of cash fee
Impairment, Long-Lived Asset, Held-for-Use, Total
Impairment, Long-Lived Asset, Held-for-Use
Impairment of property and equipment
Loss on impairment of property and equipment
Transfer of T2 owned instruments and components from inventory
Transfer of T2 owned instruments and components to (from) inventory.
Transfer Of T2 Owned Instruments And Components To From Inventory
Share-Based Payment Arrangement [Abstract]
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]
Impairment of Long-Lived Assets
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]
Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture, Total
Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture
Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan
Warrant liabilities
Derivative Warrant Liabilities Current
Derivative warrant liabilities current.
Proceeds allocated to warrants
Proceeds from Issuance of Warrants
Common Share And May 2024 Common Stock Warrant
Common Share And May 2024 Common Stock Warrant [Member]
Common Share and May 2024 Common Stock Warrant [Member]
Accounting Policies [Abstract]
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Summary of Stock Option Activity
Going concern
Going concern [Policy Text Block]
Going Concern
Inducement award plan.
Inducement Award Plan [Member]
Inducement Award Plan [Member]
Inventory, Raw Materials, Net of Reserves
Raw materials
Equity, Attributable to Parent [Abstract]
Stockholders’ deficit
Stock awards.
Stock Awards [Member]
Issuance of Stock Awards [Member]
July 31, 2023 [Member]
July Thirty One Two Thousand Twenty Three [Member]
July thirty one two thousand twenty three.
Statement [Table]
Statement [Table]
Segment Reporting, Policy [Policy Text Block]
Segment Information
Property, Plant and Equipment [Table Text Block]
Schedule of Property and Equipment
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term
Weighted-Average Remaining Contractual Term, Vested or expected to vest
Preferred stock, aggregate number of votes.
Preferred Stock, Aggregate number of Votes
Preferred stock, aggregate number of votes
Stock issued during period, shares, issuance of common stock warrant upon cashless exercises.
Stock Issued During Period, Shares, Issuance Of Common Stock Warrant Upon Cashless Exercises
Issuance of common stock upon Common Stock Warrant cashless exercises (in shares)
Subsequent Event [Table]
Preferred Stock, Shares Authorized
Preferred stock, shares authorized
Fair Value Adjustment of Warrants
Change in fair value
Change in fair value of warrants
Securities Act File Number
Entity File Number
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Net change in cash, cash equivalents and restricted cash
Revenue from Contract with Customer [Abstract]
Earnings Per Share [Abstract]
Net loss per share:
Warrants and Rights Outstanding, Term
Warrants outstanding, term
Term of lease.
Term Of Lease
Term of lease
Lease Contractual Term [Domain]
Lease Contractual Term
Statement of Financial Position [Abstract]
IPO [Member]
Public Offering [Member]
Wainwright contingent warrant.
Wainwright Contingent Warrant [Member]
Wainwright Contingent Warrant [Member]
Operating Income (Loss)
Loss from operations
Shares Issued, Price Per Share
Stated value purchase price per share
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Expected volatility
Entity Shell Company
Entity Shell Company
Accrued Professional Fees, Current
Accrued professional services
T2 Dx.
T2 Dx [Member]
T2 Dx [Member]
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
Schedule of Estimated Fair Value of the Warrant Liability
Effective interest rate
Debt Instrument, Interest Rate, Effective Percentage
Entity Tax Identification Number
Entity Tax Identification Number
Assets [Abstract]
Assets
Class of Warrant or Right [Domain]
Entity Current Reporting Status
Entity Current Reporting Status
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Weighted-Average Remaining Contractual Term, Exercisable
Change in fair value of derivative warrant liability.
Change In Fair Value Of Derivative Warrant Liability
Change in fair value of warrant liabilities
Change in fair value of warrant liabilities
Subsequent Events [Abstract]
Revenue from Contract with Customer [Policy Text Block]
Revenue Recognition
Increase (Decrease) in Contract with Customer, Liability
Deferred revenue
Geographical [Domain]
Geographical
Document Fiscal Year Focus
Document Fiscal Year Focus
Stock Option Plan 2006 [Member]
Stock Option Plan2006 [Member]
2006 Stock Option Plan [Member]
May 2024 Pre-Funded Warrants.
MayTwo Thousand Twenty Four Pre-Funded Warrants [Member]
May 2024 Pre-Funded Warrants [Member]
Preferred stock, $0.001 par value; 10,000,000 shares authorized: Series B Convertible Preferred Stock, 0 shares designated on September 30, 2024, 0 and 93,297 shares issued and outstanding to related party on September 30, 2024 and December 31, 2023, respectively
Preferred stock value
Preferred Stock, Value, Issued
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
Number of Shares, Cancelled
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total
Maximum amount of annual employee common stock purchase
Maximum Amount Of Annual Employee Common Stock Purchase
Maximum amount of annual employee common stock purchases
Derivative liabilities with placement agent
Derivative Liabilities with Placement Agent
Derivative liabilities with placement agent
Capital Expenditures Incurred but Not yet Paid
Purchases of property and equipment included in accounts payable and accrued expenses
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
Cash, cash equivalents and restricted cash at end of period
Cash, cash equivalents and restricted cash at beginning of period
Total cash, cash equivalents and restricted cash
City Area Code
City Area Code
Warrants and Rights Outstanding, Measurement Input
Warrants outstanding, measurement input
Reclassifications
Reclassification, Comparability Adjustment [Policy Text Block]
Liabilities, Current
Total current liabilities
May 2024 Common Stock Warrant.
May 2024 Common Stock Warrant [Member]
May 2024 Common Stock Warrants [Member]
Minimum liquidity covenant, waiver expiration date.
Minimum Liquidity Covenant Waiver Expiration Date
Minimum liquidity covenant, waiver expiration date
Inventories
Total inventories
Inventory, Net
Percentage of royalty on net sales.
Percentage Of Royalty On Net Sales
Percentage of royalty on net sales
Shares Converted
Conversion of Series B Convertible Preferred Stock into common stock by related party, Shares
Stock Issued During Period, Shares, Conversion of Convertible Securities
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Local Phone Number
Local Phone Number
Preferred stock, shares outstanding to related party
Preferred Stock, Shares Outstanding
Preferred Stock, Shares Outstanding, Beginning Balance
Preferred Stock, Shares Outstanding, Ending Balance
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Guarantees, Indemnifications and Warranties Policies [Policy Text Block]
Guarantees
Classification of Series A Redeemable Preferred Stock
Stockholders' Equity Note, Redeemable Preferred Stock, Issue, Policy [Policy Text Block]
Commitments and Contingencies Disclosure [Abstract]
ITALY
Italy [Member]
Maximum potential cash payout of cash fee.
Maximum Potential Cash Payout of Cash Fee
Maximum potential cash payout of cash fee
Contribution revenue.
Contribution Revenue [Member]
Contribution Revenue [Member]
Operating Lease, Liability, Current
Operating lease liabilities
Operating lease liability
Temporary Equity Disclosure [Abstract]
Debt Instrument, Interest Rate, Stated Percentage
Annual fixed rate (as a percent)
Retained Earnings [Member]
Accumulated Deficit [Member]
Prepaid and Other Current Assets [Member]
Prepaid Expenses and Other Current Assets [Member]
Payments to Acquire Property, Plant, and Equipment
Purchases and manufacture of property and equipment
Payments to Acquire Property, Plant, and Equipment, Total
Accrued Liabilities, Current [Abstract]
Document Transition Report
Document Transition Report
Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent
Percentage of full share price paid in purchase of common stock
Series A redeemable preferred stock.
Series A Redeemable Preferred Stock [Member]
Valuation Approach and Technique [Domain]
Valuation Approach and Technique
Antidilutive Security, Excluded EPS Calculation [Table]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Derivative Liability, Statement of Financial Position [Extensible Enumeration]
November fifteen two thousand twenty three.
November Fifteen Two Thousand Twenty Three [Member]
November 15, 2023 [Member]
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Weighted-Average Exercise Price Per Share, Exercised
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
Less: unamortized discount and deferred issuance costs
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net, Total
Minimum [Member]
Minimum [Member]
Common Stock [Member]
Common Stock [Member]
Restricted Cash
Minimum cash balance
Restricted Cash, Total
Minimum cash covenant after reduction
Stock issued during period value issuance of common stock and pre funded warrant upon public offering, net.
Stock Issued During Period Value Issuance Of Common Stock And Pre Funded Warrant Upon Public Offering Net
Issuance of common stock and Pre-Funded Warrant from public offering, net
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Aggregate Intrinsic Value, Vested or expected to vest
Weighted-Average Grant Date Fair Value Outstanding, Nonvested on September 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value Outstanding, Nonvested on December 31, 2023
Operating Lease, Right-of-Use Asset, Periodic Reduction
Non-cash lease expense
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Equity stock issued during period values new issues
Equity Stock Issued During Period Values New Issues
Conversion of Series A and Series B Convertible Preferred Stock into common stock by related party
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Adjustments to reconcile net loss to net cash used in operating activities:
Statement of Income Location, Balance [Domain]
Income Statement Location
Other Assets, Noncurrent
Other assets
Schedule of Inventory, Current [Table Text Block]
Schedule of Inventory
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
CRG.
C R G [Member]
CRG [Member]
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Accrued expenses and other liabilities
Disaggregation of Revenue [Line Items]
Disaggregation Of Revenue [Line Items]
Basis of Accounting, Policy [Policy Text Block]
Basis of Presentation
Wainwright Equity Distribution Agreement [Member]
Wainwright equity distribution agreement.
Stock option plans two thousand and six and two thousand and fourteen and inducement plan.
Stock Option Plans Two Thousand And Six And Two Thousand And Fourteen And Inducement Plan [Member]
2006 and 2014 Stock Option Plans and Inducement Plan [Member]
2006 and 2014 Stock Option Plans and Inducement Plan [Member]
Title and Position [Domain]
Redeemable Noncontrolling Interest [Table]
Common stock, $0.001 par value; 400,000,000 shares authorized; 18,760,092 and 4,058,381 shares issued and outstanding on September 30, 2024 and December 31, 2023, respectively
Common Stock, Value, Issued
Total purchase price
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Gain (Loss) on Disposition of Assets, Total
Gain (Loss) on Disposition of Assets
Loss on disposal of property and equipment
May 2024 Pre-Funded Warrants and May 2024 Common Stock Warrants
May 2024 Pre-Funded Warrants and May 2024 Common Stock Warrants [Member]
May 2024 Pre-Funded Warrant and May 2024 Common Stock Warrant [Member]
Other Nonoperating Income (Expense) [Abstract]
Other income (expense):
Commitments and contingencies.
Commitments And Contingencies [Line Items]
Commitments and Contingencies [Line Items]
Contingent Consideration Type [Domain]
Contingent Consideration Type
Payable of retention bonus in each installment
Payable of Retention Bonus in Each Installment
Payable of retention bonus in each installment.
Operating Lease, Liability
Lease liabilities
Operating Lease, Liability, Total
Measurement Frequency [Axis]
Measurement Frequency
Schedule of Accrued Liabilities [Table Text Block]
Components of Accrued Expenses
Commitments and Contingencies
Commitments and contingencies (see Note 14)
Expected minimum holding percentage in outstanding common stock after conversion
Expected Minimum Holding Percentage in Outstanding Common Stock After Conversion
Expected minimum holding percentage in outstanding common stock after conversion.
Minimum market value of listed securities.
Minimum Market Value Of Listed Securities
Minimum market value of listed securities
Supplemental Balance Sheet Information [Table]
Supplemental Balance Sheet Information [Table]
Supplemental Balance Sheet Information [Table]
Weighted Average Number of Shares Outstanding, Diluted
Weighted Average Number of Shares Outstanding, Diluted, Total
Weighted-average number of shares, diluted
Weighted-average number of common shares used in computing net loss per share - diluted
Redeemable Convertible Preferred Stock [Member]
Series B Redeemable Convertible Preferred Stock [Member]
Accounts Receivable, after Allowance for Credit Loss, Current
Outstanding receivable
Accounts Receivable, after Allowance for Credit Loss, Current, Total
Accounts receivable, net
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Number of Shares, Vested or expected to vest
Increase (Decrease) in Inventories
Inventories
Increase (Decrease) in Inventories, Total
Schedule of fair value of warrants.
Schedule Of Fair Value Of Warrants [Table Text Block]
Schedule of Roll-forward of Fair Value of Common Stock Warrants
Stock market value minimum required for continued listing
Stock Market Value Minimum Required for Continued Listing
Stock market value minimum required for continued listing.
Common share and common stock warrant.
Common Share and Common Stock Warrant [Member]
Concentration Risk Benchmark [Domain]
Concentration Risk Benchmark
Entity Small Business
Entity Small Business
Proceeds from private offering, net of issuance costs
Proceeds From Issuance Initial Private Offering Net Of Issuance Costs
Proceeds from private offering, net of issuance costs
Term loan warrants.
Term Loan Warrants [Member]
Term Loan Warrants [Member]
Debt Disclosure [Text Block]
Notes Payable
Series A Common Stock Warrant
Series A Common Stock Warrant [Member]
Percentage of workforce reduction.
Percentage of Workforce Reduction
Percentage of workforce reduction
Impairment of property and equipment
Production Related Impairments or Charges
Production Related Impairments or Charges, Total
Retention Bonus Payable
Retention Bonus Payable
Retention bonus payable
Stock Issued During Period, Shares, Issued for Services
Shares issued
Stockholders' Equity Note, Stock Split, Conversion Ratio
Stock split, conversion ratio
Proceeds from issuance of shares from employee stock purchase plan and stock option exercises
Proceeds From Issuance Of Shares From Employee Stock Purchase Plan And Stock Option Exercises
Proceeds from issuance of shares from employee stock purchase plan and stock option exercises.
Credit Facility [Axis]
Credit Facility
Service [Member]
Service [Member]
Percentage of common share outstanding, as it relates to the number of shares reserved for future issuance calculation under the 2014 Stock Incentive Plan.
Percentage Of Common Shares Outstanding
Percentage of common shares outstanding
The additional term for maintenance services on purchased product (which include warranty, maintenance, and technical support services) that may be purchased for additional consideration, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Maintenance Service Term Of Additional Period
Additional period for Maintenance Service option (in years)
Net Cash Provided by (Used in) Financing Activities [Abstract]
Cash flows from financing activities
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Weighted-Average Exercise Price Per Share Outstanding, end of the period
Weighted-Average Exercise Price Per Share Outstanding, beginning of the period
Placement Agent Common Stock Warrants
Placement Agent Common Stock Warrants [Member]
Placement Agent Common Stock Warrants [Member]
Debt discount amortized as interest expense
Amortization of Debt Discount (Premium)
Stockholder's equity note, warrants or rights disclosure.
Stockholder's Equity Note, Warrants or Rights Disclosure [Text Block]
Warrants
Series a and series b redeemable convertible preferred stock
Series A And Series B Redeemable Convertible Preferred Stock [Member]
Series A and Series B Redeemable Convertible Preferred Stock
Asset Class [Axis]
Measurement Frequency [Domain]
Measurement Frequency
Notes Payable, Related Party [Extensible Enumeration]
Nature of Operation, Product Information, Concentration of Risk [Table]
Schedule Of Product Information [Table]
Aggregate Intrinsic Value, Outstanding on September 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding
Balance (in shares)
Balance (in shares)
Temporary Equity, Shares Outstanding
Balance (in shares)
June Thirty Two Thousand Twenty Three.
June Thirty Two Thousand Twenty Three [Member]
June 30, 2023 [Member]
Fair Value, Inputs, Level 3 [Member]
Level 3 [Member]
Subsequent Events [Text Block]
Subsequent Events
Office and Laboratory Space [Member]
Office And Laboratory Space [Member]
Represents the information pertaining to office and laboratory space.
Accounts Payable, Current
Accounts payable
Accounts Payable, Current, Total
Percentage of minimum common stock outstanding
Percentage Of Minimum Common Stock Outstanding
Percentage of minimum common stock outstanding.
Costs and Expenses
Total costs and expenses
Liabilities, Fair Value Disclosure
Total liabilities
Maximum lease period to not recognize right of use assets or lease liabilities.
Maximum Lease Period To Not Recognize Right Of Use Assets Or Lease Liabilities
Maximum lease period to not recognize right of use assets or lease liabilities